| 25 May 2026 |
Methylene Blue |
7.0 |
10mg |
11.9mg |
+18.9% |
96.71% |
Lab B |
| 25 May 2026 |
Methylene Blue |
6.2 |
50mg |
54.5mg |
+9.1% |
99.21% |
Lab E |
| 25 May 2026 |
NAD+ Injectable |
7.3 |
100mg/ml |
110.4mg/ml |
+10.4% |
99.39% |
Lab A |
| 25 May 2026 |
Sustanon 400 |
6.5 |
100mg/ml |
118.5mg/ml |
+18.5% |
98.57% |
Lab C |
| 25 May 2026 |
Testo 600 (Test Acetate 180mg+TPP 220mg+Cyp 200mg) |
4.4 |
250mg/ml |
298.8mg/ml |
+19.5% |
97.42% |
Lab E |
| 24 May 2026 |
KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg |
4.3 |
20mg |
24.7mg |
+23.7% |
96.69% |
Lab E |
| 24 May 2026 |
Boldenone Cypionate |
5.3 |
200mg/ml |
249.5mg/ml |
+24.7% |
95.30% |
Lab D |
| 24 May 2026 |
Lipo-C FAT BLASTER |
5.9 |
300mg/ml |
280.5mg/ml |
-6.5% |
98.23% |
Lab F |
| 24 May 2026 |
Selank |
7.8 |
20mg |
24.1mg |
+20.5% |
98.74% |
Lab A |
| 24 May 2026 |
Super Shred |
7.5 |
300mg/ml |
274.5mg/ml |
-8.5% |
99.48% |
Lab B |
| 24 May 2026 |
Sustanon 400 |
6.8 |
300mg/ml |
282.1mg/ml |
-6.0% |
98.48% |
Lab E |
| 24 May 2026 |
Sustanon 400 |
7.9 |
200mg/ml |
249.7mg/ml |
+24.8% |
97.34% |
Lab A |
| 24 May 2026 |
EPO |
4.5 |
50mg |
45.8mg |
-8.4% |
95.52% |
Lab D |
| 24 May 2026 |
AICAR |
5.2 |
2mg |
2.4mg |
+21.3% |
97.71% |
Lab A |
| 24 May 2026 |
Boldenone Cypionate |
4.0 |
250mg/ml |
221.9mg/ml |
-11.2% |
95.66% |
Lab D |
| 24 May 2026 |
EPO |
5.0 |
2mg |
2.5mg |
+24.6% |
96.70% |
Lab B |
| 24 May 2026 |
Letrozole |
4.4 |
25mg |
24.0mg |
-3.8% |
98.19% |
Lab F |
| 24 May 2026 |
PTD-DBM |
7.6 |
15mg |
15.5mg |
+3.3% |
99.88% |
Lab B |
| 24 May 2026 |
PTD-DBM |
7.7 |
10mg |
10.0mg |
-0.3% |
95.99% |
Lab B |
| 24 May 2026 |
SS-31 (Elamipretide) Raw |
8.0 |
500g |
473.3g |
-5.3% |
95.32% |
Lab A |
| 24 May 2026 |
DHB (1-Test Cyp) |
5.9 |
200mg/ml |
184.6mg/ml |
-7.7% |
96.24% |
Lab C |
| 23 May 2026 |
AA Water |
7.4 |
30mg |
32.7mg |
+8.9% |
98.72% |
Lab F |
| 23 May 2026 |
Cartalax |
6.7 |
20mg |
20.7mg |
+3.6% |
96.13% |
Lab C |
| 23 May 2026 |
Cartalax |
7.2 |
15mg |
17.4mg |
+16.2% |
95.17% |
Lab C |
| 23 May 2026 |
Superdrol Oil |
5.9 |
300mg/ml |
301.3mg/ml |
+0.4% |
96.77% |
Lab A |
| 21 May 2026 |
Boldenone Cypionate |
5.4 |
100mg/ml |
113.8mg/ml |
+13.8% |
96.99% |
Lab G |
| 21 May 2026 |
Lipo-C FAT BLASTER |
5.5 |
100mg/ml |
105.1mg/ml |
+5.1% |
97.32% |
Lab G |
| 21 May 2026 |
4-Anilinopiperidine CAS 99918-43-1 |
8.0 |
5g |
6.0g |
+20.3% |
99.58% |
Lab F |
| 21 May 2026 |
Estradiol Cypionate |
4.0 |
200mg/ml |
208.0mg/ml |
+4.0% |
99.83% |
Lab D |
| 21 May 2026 |
Estradiol Cypionate |
4.4 |
200mg/ml |
240.7mg/ml |
+20.3% |
98.34% |
Lab D |
| 21 May 2026 |
Semax |
4.8 |
2mg |
2.3mg |
+16.0% |
98.13% |
Lab D |
| 20 May 2026 |
Adipotide |
8.2 |
5mg |
4.5mg |
-9.5% |
96.87% |
Lab G |
| 20 May 2026 |
Methylene Blue |
5.9 |
20mg |
22.0mg |
+10.2% |
95.06% |
Lab A |
| 20 May 2026 |
NAD+ Injectable |
4.0 |
300mg/ml |
331.1mg/ml |
+10.4% |
98.06% |
Lab B |
| 19 May 2026 |
CJC-1295 w/o DAC 10mg + IPA 10mg Blend |
6.0 |
30mg |
31.5mg |
+5.0% |
99.81% |
Lab B |
| 19 May 2026 |
Winstrol (Stanozolol) |
9.7 |
20mg |
18.2mg |
-8.8% |
97.07% |
Lab A |
| 17 May 2026 |
AA Water |
4.8 |
30mg |
37.4mg |
+24.5% |
95.43% |
Lab C |
| 17 May 2026 |
KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg |
4.0 |
15mg |
16.1mg |
+7.1% |
99.68% |
Lab B |
| 17 May 2026 |
Letrozole |
6.7 |
20mg |
18.9mg |
-5.7% |
95.43% |
Lab A |
| 17 May 2026 |
MT-1 |
6.3 |
20mg |
22.8mg |
+14.0% |
95.95% |
Lab A |
| 29 Jan 2026 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
7.2 |
30mg |
26.4mg |
-11.9% |
97.66% |
Lab A |
| 29 Jan 2026 |
Lipo-C FAT BLASTER |
5.7 |
300mg/ml |
283.1mg/ml |
-5.6% |
97.15% |
Lab A |
| 29 Jan 2026 |
MOTS-C |
5.9 |
2mg |
1.8mg |
-7.7% |
95.40% |
Lab C |
| 29 Jan 2026 |
Nandrolone Decanoate (Deca) Raw |
4.8 |
500g |
526.6g |
+5.3% |
97.83% |
Lab F |
| 29 Jan 2026 |
Pancragen |
4.0 |
20mg |
22.3mg |
+11.4% |
97.00% |
Lab C |
| 29 Jan 2026 |
Test Base (No Ester) |
4.6 |
100mg/ml |
102.0mg/ml |
+2.0% |
99.44% |
Lab F |
| 26 Jan 2026 |
Methylene Blue |
5.0 |
100mg |
107.3mg |
+7.3% |
99.22% |
Lab E |
| 26 Jan 2026 |
Superdrol Oil |
6.7 |
200mg/ml |
232.6mg/ml |
+16.3% |
98.74% |
Lab F |
| 26 Jan 2026 |
Sustanon 400 |
6.5 |
200mg/ml |
173.2mg/ml |
-13.4% |
99.03% |
Lab B |
| 19 Jan 2026 |
Cerebrolysin |
6.2 |
5mg |
5.8mg |
+15.2% |
98.34% |
Lab G |
| 19 Jan 2026 |
Letrozole |
6.2 |
10mg |
8.9mg |
-11.2% |
95.65% |
Lab A |
| 19 Jan 2026 |
Selank |
7.8 |
15mg |
18.3mg |
+21.7% |
97.66% |
Lab F |
| 19 Jan 2026 |
Turinabol |
4.6 |
50mg |
56.4mg |
+12.9% |
95.69% |
Lab D |
| 9 Jan 2026 |
SLU-PP-332 250mcg + BAM15 50mcg Blend |
6.6 |
10mg |
9.5mg |
-5.1% |
99.59% |
Lab A |
| 9 Jan 2026 |
Turinabol |
6.8 |
10mg |
12.5mg |
+24.7% |
96.42% |
Lab C |
| 9 Jan 2026 |
Turinabol |
7.5 |
25mg |
28.5mg |
+14.2% |
97.74% |
Lab D |
| 7 Jan 2026 |
AA Water |
7.7 |
2mg |
2.4mg |
+20.3% |
96.79% |
Lab F |
| 7 Jan 2026 |
AA Water |
7.4 |
2mg |
1.8mg |
-11.8% |
99.78% |
Lab G |
| 7 Jan 2026 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
5.2 |
10mg |
10.5mg |
+5.3% |
97.63% |
Lab D |
| 7 Jan 2026 |
Superdrol Oil |
5.7 |
100mg/ml |
110.7mg/ml |
+10.7% |
95.02% |
Lab F |
| 7 Jan 2026 |
Test Base (No Ester) |
4.0 |
250mg/ml |
292.6mg/ml |
+17.0% |
96.62% |
Lab F |
| 7 Jan 2026 |
Testo 600 (Test Acetate 180mg+TPP 220mg+Cyp 200mg) |
7.7 |
100mg/ml |
125.0mg/ml |
+25.0% |
99.62% |
Lab G |
| 6 Jan 2026 |
BPC-157 Arg Oral |
8.4 |
50mg |
54.0mg |
+7.9% |
99.67% |
Lab D |
| 6 Jan 2026 |
EPO |
5.5 |
30mg |
30.2mg |
+0.7% |
96.17% |
Lab F |
| 6 Jan 2026 |
Estradiol Cypionate |
4.0 |
250mg/ml |
306.4mg/ml |
+22.6% |
97.18% |
Lab E |
| 6 Jan 2026 |
MOTS-C |
7.4 |
2mg |
2.1mg |
+3.0% |
95.96% |
Lab F |
| 6 Jan 2026 |
Nandrolone Decanoate (Deca) Raw |
7.7 |
1g |
1.1g |
+10.7% |
99.70% |
Lab E |
| 29 Dec 2025 |
AICAR |
5.4 |
30mg |
31.4mg |
+4.8% |
98.92% |
Lab F |
| 29 Dec 2025 |
EPO |
4.0 |
20mg |
21.4mg |
+7.0% |
97.18% |
Lab F |
| 29 Dec 2025 |
MOTS-C |
7.4 |
5mg |
4.8mg |
-4.7% |
99.13% |
Lab G |
| 29 Dec 2025 |
Nandrolone Decanoate (Deca) Raw |
7.6 |
5g |
5.1g |
+1.1% |
99.24% |
Lab C |
| 29 Dec 2025 |
Semax |
5.1 |
10mg |
11.6mg |
+16.3% |
99.62% |
Lab C |
| 29 Dec 2025 |
Turinabol |
7.2 |
25mg |
22.8mg |
-8.8% |
96.10% |
Lab F |
| 12 Dec 2025 |
AICAR |
6.9 |
10mg |
9.5mg |
-5.4% |
97.43% |
Lab D |
| 12 Dec 2025 |
Boldenone Cypionate |
4.0 |
250mg/ml |
290.3mg/ml |
+16.1% |
98.00% |
Lab E |
| 12 Dec 2025 |
Lipo-C FAT BLASTER |
4.2 |
250mg/ml |
309.4mg/ml |
+23.8% |
96.28% |
Lab B |
| 12 Dec 2025 |
Methylene Blue |
4.2 |
25mg |
22.2mg |
-11.4% |
99.04% |
Lab G |
| 12 Dec 2025 |
MK-677 (Ibutamoren) |
9.8 |
25mg |
27.3mg |
+9.3% |
96.48% |
Lab G |
| 12 Dec 2025 |
MOTS-C |
6.3 |
2mg |
1.8mg |
-10.4% |
96.02% |
Lab D |
| 11 Dec 2025 |
Retatrutide |
7.3 |
10mg |
10.4mg |
+4.0% |
99.62% |
Lab E |
| 5 Dec 2025 |
Tirzepatide |
6.7 |
10mg |
9.4mg |
-6.0% |
99.50% |
Lab G |
| 5 Dec 2025 |
AA Water |
4.2 |
10mg |
10.8mg |
+8.1% |
99.69% |
Lab B |
| 5 Dec 2025 |
Estradiol Cypionate |
4.1 |
200mg/ml |
233.3mg/ml |
+16.6% |
98.20% |
Lab F |
| 5 Dec 2025 |
MT-1 |
7.8 |
20mg |
20.5mg |
+2.3% |
96.61% |
Lab A |
| 5 Dec 2025 |
SLU-PP-332 250mcg + BAM15 50mcg Blend |
5.1 |
100mg |
85.3mg |
-14.7% |
97.91% |
Lab C |
| 2 Dec 2025 |
Retatrutide |
5.8 |
10mg |
9.2mg |
-8.0% |
99.40% |
Lab G |
| 25 Nov 2025 |
Retatrutide |
10.0 |
10mg |
9.95mg |
-0.5% |
99.95% |
Lab E |
| 23 Nov 2025 |
MK-677 (Ibutamoren) |
7.6 |
50mg |
47.4mg |
-5.2% |
99.04% |
Lab C |
| 23 Nov 2025 |
NAD+ Injectable |
4.2 |
200mg/ml |
196.3mg/ml |
-1.8% |
96.47% |
Lab D |
| 23 Nov 2025 |
Selank |
6.8 |
2mg |
2.3mg |
+16.0% |
97.00% |
Lab E |
| 23 Nov 2025 |
Testo 600 (Test Acetate 180mg+TPP 220mg+Cyp 200mg) |
6.6 |
100mg/ml |
97.7mg/ml |
-2.3% |
95.37% |
Lab A |
| 23 Nov 2025 |
Vilon |
8.3 |
30mg |
34.0mg |
+13.4% |
96.26% |
Lab E |
| 17 Nov 2025 |
Boldenone Cypionate |
4.0 |
250mg/ml |
227.6mg/ml |
-9.0% |
95.74% |
Lab C |
| 17 Nov 2025 |
Dapoxetine |
7.8 |
10mg |
9.9mg |
-1.1% |
95.77% |
Lab F |
| 17 Nov 2025 |
DHB (1-Test Cyp) |
4.0 |
100mg/ml |
120.8mg/ml |
+20.8% |
96.43% |
Lab B |
| 17 Nov 2025 |
Nandrolone Decanoate (Deca) Raw |
8.4 |
1g |
1.1g |
+12.9% |
96.50% |
Lab B |
| 17 Nov 2025 |
Vilon |
6.9 |
2mg |
2.0mg |
-1.4% |
97.61% |
Lab C |
| 14 Nov 2025 |
Turinabol |
4.8 |
50mg |
46.5mg |
-7.1% |
98.02% |
Lab C |
| 5 Nov 2025 |
AICAR |
6.9 |
15mg |
17.0mg |
+13.2% |
97.85% |
Lab G |
| 5 Nov 2025 |
Estradiol Cypionate |
4.4 |
200mg/ml |
232.6mg/ml |
+16.3% |
95.00% |
Lab D |
| 5 Nov 2025 |
NAD+ Injectable |
5.9 |
100mg/ml |
120.2mg/ml |
+20.2% |
97.16% |
Lab C |
| 5 Nov 2025 |
Pancragen |
4.9 |
30mg |
32.9mg |
+9.6% |
97.83% |
Lab B |
| 4 Nov 2025 |
Adipotide |
9.9 |
50mg |
59.8mg |
+19.5% |
97.60% |
Lab C |
| 4 Nov 2025 |
CJC-1295 w/o DAC 10mg + IPA 10mg Blend |
6.4 |
2mg |
2.5mg |
+24.2% |
98.44% |
Lab F |
| 4 Nov 2025 |
KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg |
4.0 |
5mg |
4.5mg |
-9.1% |
96.04% |
Lab D |
| 4 Nov 2025 |
SS-31 (Elamipretide) Raw |
6.7 |
100g |
123.4g |
+23.4% |
99.06% |
Lab D |
| 17 Oct 2025 |
Retatrutide |
8.0 |
40mg |
40.6mg |
+1.5% |
99.95% |
Lab E |
| 17 Oct 2025 |
4-Anilinopiperidine CAS 99918-43-1 |
5.1 |
1g |
1.0g |
+1.8% |
99.14% |
Lab D |
| 17 Oct 2025 |
Vilon |
5.6 |
50mg |
57.2mg |
+14.3% |
95.88% |
Lab F |
| 17 Oct 2025 |
Winstrol (Stanozolol) |
7.5 |
20mg |
22.3mg |
+11.7% |
99.37% |
Lab C |
| 9 Oct 2025 |
AICAR |
6.3 |
20mg |
20.7mg |
+3.4% |
98.42% |
Lab G |
| 9 Oct 2025 |
Liraglutide |
8.7 |
30mg |
31.6mg |
+5.2% |
95.30% |
Lab A |
| 9 Oct 2025 |
SLU-PP-332 250mcg + BAM15 50mcg Blend |
4.3 |
50mg |
54.7mg |
+9.4% |
98.81% |
Lab F |
| 9 Oct 2025 |
SS-31 (Elamipretide) Raw |
6.2 |
1g |
1.0g |
+2.5% |
97.30% |
Lab C |
| 9 Oct 2025 |
SS-31 (Elamipretide) Raw |
6.4 |
10g |
8.8g |
-12.0% |
96.73% |
Lab C |
| 3 Oct 2025 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
7.8 |
30mg |
28.4mg |
-5.2% |
97.70% |
Lab G |
| 3 Oct 2025 |
Testo 600 (Test Acetate 180mg+TPP 220mg+Cyp 200mg) |
6.2 |
100mg/ml |
112.6mg/ml |
+12.6% |
97.49% |
Lab B |
| 20 Sep 2025 |
GHK-Cu |
4.9 |
50mg |
34.6mg |
-30.8% |
100.00% |
Lab G |
| 20 Sep 2025 |
GHK-Cu |
4.8 |
50mg |
31.2mg |
-37.6% |
100.00% |
Lab G |